Renaissance Technologies LLC lifted its holdings in shares of Electromed, Inc. (NYSEAMERICAN:ELMD) by 16.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 102,340 shares of the medical equipment provider’s stock after acquiring an additional 14,100 shares during the quarter. Renaissance Technologies LLC owned approximately 1.22% of Electromed worth $558,000 as of its most recent SEC filing.
Separately, Teton Advisors Inc. boosted its stake in shares of Electromed by 28.6% during the 2nd quarter. Teton Advisors Inc. now owns 159,843 shares of the medical equipment provider’s stock worth $871,000 after acquiring an additional 35,507 shares during the period.
Separately, TheStreet downgraded Electromed from a “b-” rating to a “c+” rating in a research note on Tuesday, June 25th.
Electromed (NYSEAMERICAN:ELMD) last released its quarterly earnings results on Tuesday, August 27th. The medical equipment provider reported $0.13 earnings per share (EPS) for the quarter. The firm had revenue of $8.60 million during the quarter.
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.
Read More: Trading Options- What is a Strangle?
Want to see what other hedge funds are holding ELMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Electromed, Inc. (NYSEAMERICAN:ELMD).
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.